Chinese Medicine Injection Shuanghuanglian for Treatment of Acute Upper Respiratory Tract Infection: A Systematic Review of Randomized Controlled Trials | Zendy

Hongwei Zhang | Zendy; Qin Chen | Zendy; Weiwei Zhou | Zendy; Shi Gao | Zendy; Lin HuiGuang | Zendy; Shuifen Ye | Zendy; Yihui Xu | Zendy; Jing Cai | Zendy

Open Access

Chinese Medicine Injection Shuanghuanglian for Treatment of Acute Upper Respiratory Tract Infection: A Systematic Review of Randomized Controlled Trials

Author(s) -

Hongwei Zhang,

Qin Chen,

Weiwei Zhou,

Shi Gao,

Lin HuiGuang,

Shuifen Ye,

Yihui Xu,

Jing Cai

Publication year - 2013

Publication title -

evidence-based complementary and alternative medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.552

H-Index - 90

eISSN - 1741-4288

pISSN - 1741-427X

DOI - 10.1155/2013/987326

Subject(s) - scutellaria baicalensis , medicine , respiratory tract , respiratory tract infections , honeysuckle , traditional chinese medicine , upper respiratory tract infection , randomized controlled trial , respiratory system , intensive care medicine , traditional medicine , pathology , alternative medicine

Acute upper respiratory tract infections (AURTIs) are the illnesses caused by an acute infection with various viruses and bacteria involving the upper respiratory tract. Shuanghuanglian (SHL) injection, a Chinese medicine intravenous preparation extracted from honeysuckle, Scutellaria baicalensis , and fructus forsythiae, is commonly used to treat AURTIs. Although it is used largely in Chinese hospitals, there is no substantial evidence to demonstrate its clinical effect on AURTIs. We conducted a systematic review to evaluate the effectiveness and safety of Shuanghuanglian injection for the treatment of acute upper respiratory tract infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research